XBI SPDR S&P Biotech ETF

Rough week for biotech. $XBI just had its worst week of the year and half the feed is calling it capitulation. This is usually where the next runup list gets built. $MRNA has Phase 3 melanoma data at ESMO on Oct 24 and $SLS is still pulling some of the heaviest retail attention on the platform. Watching both into Monday.

The indiscriminate dumping in biotech over the last few weeks is wild to watch... it's gotten completely mindless at this point. Pure liquidation mode. I’ve been doing the opposite. Stepping up and buying the weakness. Adding to several positions and starting fresh ones where the dislocation is just getting stupid. When the tape gets this washed out, patient buyers get rewarded, IMO. Not trying to nail the exact bottom, just scaling into names I want to own while panic takes over. $XBI $IBB $IWM $VKTX $KLRA

Market doing what it does best. Sector rotation out of biotechs $XBI back to AI big tech, for now, as importantly we start Q4 this week. So a rinse/repeat of the cycle but year end outlook is strong. Clearing out lots of stop losses, shaking the tree, chasing out weak hands. Long term thesis $IOVA is intact with multiple catalysts straight ahead.

$XBI $SLS is the next $MRNA Moderna has now added $60B to its market cap since its Phase 3 Cancer Vaccine Results were announced. Sellas Life Sciences Phase 3 Cancer Vaccine Results for AML Remission Maintenance are now Imminent. $2.3B baby bio about to be $25B and climbing - it will happen any day now. I’ve been here a while scroll my posts for DD. Investment Opportunity of a Lifetime.

$XBI I think xbi has just two stocks sls and ibrx. This board is overrun with these two tickers non stop.

$XBI $SLS $MRNA Cash for Sure Matter - So does the Relative market value / Market Capitalization for these Big Pharma's -- $LLY for instance has a $1.08T T - Trillion Dollar Market Cap/ could issue / buy SLS $0.023T and not even Notice...

$XBI rising yields -so XBI macro is tough- But there are amzing, selective, diamonds in the rough being wrongfully associated with the macro. Companies with approved drugs- growing revs. and applications $AUPH is highly profitable, growth play. $SNDX Well capitalized and executing with 2 amazing-approved drugs. Buy the solid co's where baby being being thrown out with the bath water. Avoid anything that needs to raise $ and has no rev. generation.

Small and mid cap biotech has been on a run all year, $XBI up 29% YTD. $DRTS rode that wave too, up 198% YTD and consolidating just under its highs.

$XBI bear markets don’t start with everyone panicking over a sustained and rapid downtrend. bear markets are death by a thousand cuts and when everyone is still bullish. this is a pullback.

So if any of you feel like it's especially hard out there currently, you're not wrong! $XBI

$XBI pretty gross *could* roll chop til end of year. wouldnt surprise after a monster run

$XBI When rates go up...biotech gets scorched. Don't overthink it. What you could do is get rid of the maniac/retard you call a President. That would at least stop rates from going to levels last seen in the 80's.

$XBI $OCUL NDA in the coming weeks. 🚀 sooon !!! An excellent buy right now, at the low end of the market.

Q: Hi JF, Do you think $XBI will recover soon? It looks like a very hard time. A: Anyone's guess my friend- No crystal ball from my end unfortunately. Much like Jose and others on here, I try to focus on thesis progression for each holding and tune out the noise. That helps with staying even keel with my emotions and productive time use, but the tough thing about rough patches (I've found at least) is you never know how long they'll last.

$XBI needs a big data pr, likely many coming in November ir M&A to get back in fashion. Otherwise subject to rates and rotation which never favor us unless rate cut is on the table which is definitely not

$XBI a common feeling in biotech. Sinking feeling but common nonetheless. we go first, but we also recover first. not seeing the volume on the small caps that cause concern… yet

$XBI Quality bios like CELC, MLYS and VERA underperformed the XBI by at least 55-70% YTD. Just FYI.

$XBI just buy Sellas guys, about to pop off again and stay that way. Congrats on avoiding the slog of a summer but it is go time now. IMO nfa dyor.

"Why do you invest in biotech?" $XBI A simple question, but led to great discussion this week- a few answers: "Learned to consistently make $$ doing this" "Offsetting capital gains from other sectors" 😂 "Stay current with technological innovations & advances in healthcare" "Rewards of LT compounding" "Intellectual stimulation- keeps me sharp"

$XBI $ARKG today made no sense - barely any of these names popped bc of a stupid plague scare - they were holding sustained gains for at least a month in a sector that has extremely punishing volatility - the downside was coming for some of the more bloated tickers like $TWST but overall this was such a crazy over reaction that i can’t quite wrap my head around. the dance between biotech and ai just feels like a horrible game of whack a mole designed to screw retailers with asymmetric access to information.